Fennec Pharmaceuticals (FENC) Receivables - Net (2022 - 2025)

Fennec Pharmaceuticals (FENC) has 4 years of Receivables - Net data on file, last reported at $23.2 million in Q4 2025.

• For the quarter ending Q4 2025, Receivables - Net rose 80.23% year-over-year to $23.2 million; the trailing twelve-month figure through Dec 2025 stood at $23.2 million (up 80.23% YoY), and the FY2025 full-year result was $23.2 million, up 80.23% from the prior year.
• Receivables - Net for Q4 2025 stood at $23.2 million, up from $19.3 million in the prior quarter.
• Across five years, Receivables - Net topped out at $23.2 million in Q4 2025 and bottomed at $1.5 million in Q4 2022.
• The 4-year median for Receivables - Net is $12.3 million (2024), against an average of $11.0 million.
• The widest annual swing landed in 2024, when Receivables - Net soared 510.46%; it then surged 42.15% in 2025.
• A 4-year view of Receivables - Net shows it stood at $1.5 million in 2022, then soared by 470.49% to $8.8 million in 2023, then surged by 46.18% to $12.9 million in 2024, then soared by 80.23% to $23.2 million in 2025.
• The last three Receivables - Net figures came in at $23.2 million (Q4 2025), $19.3 million (Q3 2025), and $17.5 million (Q2 2025), per Business Quant data.

Peer Comparison